快报
欢迎光临蚂蚁淘在线！ 请登录 免费注册
商品
品牌
文章
热门搜索：
快报
品牌首页 品牌新闻 品牌简介 产品中心 品牌咨询 联系我们
品牌分类
品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com
蚂蚁淘在线 / 品牌中心 / CHROMOGENIX / CHROMOGENIX/Calibrators & Controls/4x1 ml/82 3500 63

CHROMOGENIX/Calibrators & Controls/4x1 ml/82 3500 63

价格
面议
货号：82350063
浏览量：127
品牌：CHROMOGENIX
服务
全国联保
正品保证
正规发票
签订合同
商品描述
About usIProductsITechnology
Package InsertsIMSDS
  • Products
    • Haemostasis Kits
    • Calibrators & Controls
      • CALIBRATION PLASMA-LMW...
      • CONTROL PLASMA-LMW...
      • CONTROL PLASMA LEVEL 1...
      • CONTROL PLASMA LEVEL 2...
    • Bio-Reagents
    • Chromogenic Substrates

CALIBRATION PLASMA-LMW HEPARIN

Composition

Lyophilised human plasma, prepared by addition of heparin. Calibrated against the 1st International WHO standard (LMW heparin).

Application

For construction of calibration curves for use in chromogenic heparin assays.

Package

calibrator 1
4x1 ml
calibrator 2
4x1 ml
calibrator 3
4x1 ml

Part Number: 82 3500 63

CONTROL PLASMA-LMW HEPARIN

Composition

Lyophilised human plasma prepared by addition of LMW heparin. Calibrated against the 1st International WHO standard (LMW heparin).

Application

Quality control of chromogenic heparin assays.

Package

High
4x1 ml
Low
4x1 ml

Part Number: 82 3492 63

CONTROL PLASMA LEVEL 1 COATEST® APCTM RESISTANCE

Composition

Lyophilised citrated, stabilised human plasma prepared from pools of plasma collected from healthy donors.

Application

Quality control of Coatest® APCTM Resistance and Coatest® APCTM Resistance V.

Package

5x1 ml

Part Number: 82 2650 63

CONTROL PLASMA LEVEL 2 COATEST® APCTM RESISTANCE

Composition

Lyophilised citrated, stabilised human plasma prepared from pools of plasma collected from donors carrying theFactor V:Q506 mutation.

Application

Quality control of Coatest® APCTM Resistance and Coatest® APCTM Resistance V.

Package

5x1 ml

Part Number: 82 2668 63

CHROMOGENIX的COATEST TM APC TM电阻基于APTT的检测APC抗性表型的方法，即对活化蛋白C（APC）的抗凝反应较差。测试结果（APC比）提供了体内抗凝功能的估计值，并提供了与遗传性和获得性APC抗性相关的血栓形成风险的信息。